NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $1,629,000 | +2.6% | 95,812 | +0.1% | 0.03% | -9.7% |
Q3 2020 | $1,588,000 | -29.7% | 95,750 | -1.8% | 0.03% | -32.6% |
Q2 2020 | $2,259,000 | +35.3% | 97,538 | +4.2% | 0.05% | +17.9% |
Q1 2020 | $1,670,000 | -17.3% | 93,570 | 0.0% | 0.04% | 0.0% |
Q4 2019 | $2,020,000 | +344.0% | 93,570 | +274.7% | 0.04% | +290.0% |
Q3 2019 | $455,000 | -48.5% | 24,971 | +0.5% | 0.01% | -47.4% |
Q2 2019 | $884,000 | +5.9% | 24,859 | +0.1% | 0.02% | +11.8% |
Q1 2019 | $835,000 | +4.1% | 24,838 | +1.8% | 0.02% | -15.0% |
Q4 2018 | $802,000 | -45.7% | 24,402 | +0.6% | 0.02% | -35.5% |
Q3 2018 | $1,478,000 | +33.9% | 24,245 | +7.3% | 0.03% | +24.0% |
Q2 2018 | $1,104,000 | -53.7% | 22,605 | +0.8% | 0.02% | -55.4% |
Q1 2018 | $2,382,000 | -2.6% | 22,416 | -45.3% | 0.06% | 0.0% |
Q4 2017 | $2,446,000 | +157.5% | 40,956 | +3.4% | 0.06% | +143.5% |
Q3 2017 | $950,000 | +27.0% | 39,593 | +3.5% | 0.02% | +21.1% |
Q2 2017 | $748,000 | -11.4% | 38,261 | +6.4% | 0.02% | -13.6% |
Q1 2017 | $844,000 | +105.9% | 35,971 | +7.7% | 0.02% | +100.0% |
Q4 2016 | $410,000 | -15.3% | 33,397 | +18.6% | 0.01% | -21.4% |
Q3 2016 | $484,000 | +27.7% | 28,148 | +5.7% | 0.01% | +27.3% |
Q2 2016 | $379,000 | +14.2% | 26,638 | +10.2% | 0.01% | +10.0% |
Q1 2016 | $332,000 | -8.3% | 24,165 | +12.3% | 0.01% | -9.1% |
Q4 2015 | $362,000 | +69.2% | 21,509 | +10.3% | 0.01% | +57.1% |
Q3 2015 | $214,000 | +1.4% | 19,502 | +15.8% | 0.01% | +16.7% |
Q2 2015 | $211,000 | – | 16,838 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
TOBAM | 640,547 | $21,522,000 | 1.09% |
Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |